Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02519244 · ClinicalTrials.gov registry record · NA

Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT02519244 is a NA study of Multiple Sclerosis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 11 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02519244, a NA study of Multiple Sclerosis, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate whether a wearable robotic exoskeleton can help people with multiple sclerosis (MS) to walk again.

Conditions Studied

Interventions

  • DEVICE Ekso® (Wearable lower limb exoskeleton)

Study Locations (1)

Texas

  • TIRR Memorial Hermann - Houston

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-05
Est. Completion 2017-02-06
Phase NA

What the Registry Record Tells You About NCT02519244

The ClinicalTrials.gov registry entry for NCT02519244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Ekso® (Wearable lower limb exoskeleton) is the first listed.

NCT02519244 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02519244 about?

NCT02519244 is a clinical study titled "Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis". The purpose of this study is to investigate whether a wearable robotic exoskeleton can help people with multiple sclerosis (MS) to walk again.

What is the current status of trial NCT02519244?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-05. Estimated completion is 2017-02-06.

What conditions does trial NCT02519244 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02519244?

The interventions under investigation include: Ekso® (Wearable lower limb exoskeleton) (DEVICE).

Who is sponsoring clinical trial NCT02519244?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02519244 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.